1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005 Oct; 33(10): 2184-93. doi: 10.1097/01.ccm.0000181731.53912.d9 [ DOI] [ PubMed] 2. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010 May; 340: c2096. doi: 10.1136/bmj.c2096 [ DOI] [ PubMed] 3. Pepys MB. C-reactive protein fifty years on. Lancet. 1981 Mar; 1(8221): 653-57. doi: 10.1016/s0140-6736(81)91565-8 [ DOI] [ PubMed] 4. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb; 265(3): 621-36. doi: 10.1042/bj2650621 [ DOI] [ PubMed] 5. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996 Nov; 174(5): 994-1000. doi: 10.1093/infdis/174.5.994 [ DOI] [ PubMed] 6. Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J. 2008 Sep; 32(3): 726-32. doi: 10.1183/09031936.00003608 [ DOI] [ PubMed] 7. Lacoma A, Prat C, Andreo F, Lores L, Ruiz-Manzano J, Ausina V, et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011; 6: 157-69. doi: 10.2147/COPD.S16070 [ DOI] [ PubMed] 8. Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med. 2008 Apr; 36(4): 1147-54. doi: 10.1097/CCM.0b013e3181692966 [ DOI] [ PubMed] 9. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007 Mar; 7(3): 210-17. doi: 10.1016/S1473-3099(07)70052-X [ DOI] [ PubMed] 10. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care. 2006; 10(5): R125. doi: 10.1186/cc5036 [ DOI] [ PubMed] 11. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009 Dec; 34(6): 1364-75. doi: 10.1183/09031936.00053209 [ DOI] [ PubMed] 12. Bruun T, Loewer HL. Prevalence surveillance system of nosocomial infections in Norway. Euro Surveill. 2007 Aug; 12(8): E070830.2. doi: 10.2807/esw.12.35.03258-en [ DOI] [ PubMed] 13. Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA. 2013 Feb; 309(7): 717-18. doi: 10.1001/jama.2013.697 [ DOI] [ PubMed] 14. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010 Jan; 50(2): 202-209. doi: 10.1086/648678 [ DOI] [ PubMed] 15. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb; 171(4): 388-416. doi: 10.1164/rccm.200405-644ST [ DOI] [ PubMed] 16. Martin-Loeches I, Povoa P, Rodríguez A, Curcio D, Suarez D, Mira JP, Cordero ML, et al. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study. Lancet Respir Med. 2015 Nov; 3(11): 859-68. doi: 10.1016/S2213-2600(15)00326-4 [ DOI] [ PubMed] 17. Ko M, Lee Y, Chen C, Chou P, Chu D. Prevalence of and Predictors for Frequent Utilization of Emergency Department: A Population-Based Study. Medicine (Baltimore). 2015 Jul; 94(29): e1205. doi: 10.1097/MD.0000000000001205 [ DOI] [ PubMed] 18. Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010; 14(1): 203. doi: 10.1186/cc8155 [ DOI] [ PubMed] 19. Zielińska-Borkowska U, Skirecki T, Złotorowicz M, Czarnocka B. Procalcitonin in early onset ventilator-associated pneumonia. J Hosp Infect. 2012 Jun; 81(2): 92-97. doi: 10.1016/j.jhin.2012.02.011 [ DOI] [ PubMed] 20. Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008 Jul; 52(1): 48-58.e2. doi: 10.1016/j.annemergmed.2008.01.003 [ DOI] [ PubMed] 21. Chen C, Yan M, Hu C, Lv X, Zhang H, Chen S. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia. Med Sci (Paris). 2018 Oct; 34 Focus issue F1: 26-32. doi: 10.1051/medsci/201834f105 [ DOI] [ PubMed] 22. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J. 2005 May; 25(5): 804-12. doi: 10.1183/09031936.05.00071704 [ DOI] [ PubMed] 23. Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J. 2010 Apr; 35(4): 805-11. doi: 10.1183/09031936.00051309 [ DOI] [ PubMed] 24. Mourad S, Rajab M, Alameddine A, Fares M, Ziade F, Merhi BA. Hemoglobin level as a risk factor for lower respiratory tract infections in Lebanese children. N Am J Med Sci. 2010 Oct; 2(10): 461-66. doi: 10.4297/najms.2010.2461 [ DOI] [ PubMed] |
